https://www.selleckchem.com/pr....oducts/crenolanib-cp
There is widespread acknowledgement that coronavirus disease 2019 (COVID-19) has disrupted surgical services. The European Society of Thoracic Surgeons (ESTS) sent out a survey to assess what impact the COVID-19 pandemic has had on the practice of thoracic oncology surgery. All ESTS members were invited (13-20 April 202 to complete an online questionnaire of 26 questions, designed by the ESTS learning affairs committee. The response rate was 23.0% and the completeness rate was 91.2%. The number of treated COVID-positive c
Like
Comment
Share
